Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Michael J Fox webinar

Resources & Tools

WEBINAR – Tune in for the Michael J Fox Foundation 2016 round-up

Register for this free live webinar

READ MORE
Meal Soup lead

Recipes & Nutrition

In the kitchen with Yves: why meal soups are good for you

Turning soup into a filling dish that is easy to chew and swallow

READ MORE

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

A roundup of the Parkinson’s Life podcast

READ MORE